Off-Label Use of Ceftolozane/Tazobactam for the Successful Treatment of Healthcare-Associated Meningitis Caused by Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> in a Polytraumatized Patient—A Case Report

Background: Hospital-acquired infections with extensively drug-resistant (XDR) <i>Pseudomonas aeruginosa</i> (PA) have become a worrisome concern because of unfavorable outcomes and limited antimicrobial treatment options. Studies with new antimicrobial substances against XDR-PA show very promising...

Cijeli opis

Bibliografski detalji

Glavni autori:	Simon Dubler, Thorsten Brenner, Stefan Zimmermann, Theresa Mokry, Anka Röhr, Daniel C. Richter, Alexandra Heininger, Markus A. Weigand
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2022-08-01
Serija:	Reports
Teme:	ceftolozan/tazobactam <i>Pseudomonas aeruginosa</i> drug resistance case report meningitis
Online pristup:	https://www.mdpi.com/2571-841X/5/3/33
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!